Access Optics is a leading manufacturer for medical device and defense OEMs worldwide, specializing in precision and micro-scale optics, high-reliability subassemblies, and complete devices for the medtech, diagnostic imaging, and analytical instrumentation markets. With certifications including ISO 13485, ISO 9001, ITAR, and FDA registration, the company is dedicated to pioneering product development and advanced materials solutions, serving prominent OEMs in various industries including endoscopy, dermatology, aerospace, and chromatography.
Founded in 2000 and headquartered in the United States, Access Optics recently received a $4.50M Series A investment on 25 October 2021 from notable investors such as Santé Ventures, Atento Capital, Cortado Ventures, Oklahome Life Science Fund, and Plains Ventures.
Embodying the mission to solve the unsolvable, Access Optics' technology and manufacturing capabilities enable the development of optical assemblies and hermetic seals that resist extreme environmental conditions, setting new standards in the industry. The company's values, known as the "AO Way," are centered around innovation, exceeding expectations, and exceptional quality, forming the foundation of its corporate culture and operations.